2-唑烷酮 、 苯佐卡因盐酸盐 以
various solvent(s) 为溶剂,
以61%的产率得到ethyl 4-(ethylenediamine)benzoate
参考文献:
名称:
The use of 2-oxazolidinones as latent aziridine equivalents. 2. Aminoethylation of aromatic amines, phenols, and thiophenols
摘要:
The utility of 2-oxazolidinones 1 as latent, carboxylated aziridine functionalities was examined. Reaction of 2-oxazolidinone (1a), 3-methyl-2-oxazolidinone (1b), 3-(phenylmethyl)-2-oxazolidinone (1c), 3-phenyl-2-oxazolidinone (1d), 4,4-dimethyl-2-oxazolidinone (1e), and 5-ethyl-2-oxazolidinone (1f) with aromatic amine salts, phenol, or thiophenols at elevated temperatures (> 130-degrees-C) afforded aminoethylated adducts. The aminoethylation occurred with concomitant loss of carbon dioxide to furnish variously substituted N-aryl-1,2-ethanediamines 4, 1-(2-phenoxyethyl)-2-imidazolidinone (8), or 2-(arylthio)ethanamines 9 on reactions of 1 with aromatic amine salts, phenol, and thiophenols, respectively. Imidazolidinone 8 is believed to be a secondary reaction product resulting from the condensation of the initially formed 2-phenoxyethanamine with starting oxazolidinone 1a. The aminoethylation reaction did not proceed with aliphatic amine hydrochlorides or alkyl mercaptans. Preliminary mechanistic pathways for these ring openings were also investigated employing a specific, C-5 deuterium-labeled oxazolidinone 1b-d2. Ring-opening experiments of 1b-d2 with N-methylaniline hydrochloride suggest reaction can occur through either a dioxazolinium 5 and/or an aziridinium 6 intermediate. In contrast, reaction of 1b-d2 with thiophenol suggests ring-opening to proceed only via the dioxazolinium pathway.
[EN] C-28 AMIDES OF MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS<br/>[FR] AMIDES C-28 DE DÉRIVÉS D'ACIDE BÉTULINIQUE MODIFIÉS EN C-3, UTILISÉS COMME INHIBITEURS DE MATURATION DU VIH
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2011153319A1
公开(公告)日:2011-12-08
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, modified C-3 and C-28 betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors. These compounds are useful for the treatment of HIV and AIDS.
Development of an S<sub>N</sub>Ar Reaction: A Practical and Scalable Strategy To Sequester and Remove HF
作者:A. John Blacker、Gabriel Moran-Malagon、Lyn Powell、William Reynolds、Rebecca Stones、Michael R. Chapman
DOI:10.1021/acs.oprd.8b00090
日期:2018.9.21
simple and operationally practical method to sequester and remove fluoride generated through the SNAr reaction between amines and aryl fluorides is reported. Calcium propionate acts as an inexpensive and environmentally benign in situ scrubber of the hydrofluoricacid byproduct, which is simply precipitated and filtered from the reaction mixture during standard aqueous workup. The method has been tested
报道了一种简单且操作上可行的方法,用于隔离和去除通过胺与芳基氟化物之间的S N Ar反应生成的氟化物。丙酸钙可作为氢氟酸副产物的廉价且对环境无害的原地洗涤器,在标准的水后处理过程中,氢氟酸副产物可以简单地从反应混合物中沉淀出来并过滤掉。该方法已在10到100 g的操作规模上进行了测试,显示在每种情况下氟化物含量均降低> 99.5%。两种规模的氟化钙都得到了全面的回收,这证明这是一种通用,有效且健壮的氟化物提取方法,有助于防止搪玻璃反应堆腐蚀。
Aminoethylation process
申请人:The Dow Chemical Company
公开号:US04381401A1
公开(公告)日:1983-04-26
2-Oxazolidinone or N-substituted derivatives thereof are reacted with aromatic amine hydrochlorides at elevated temperatures to produce 1,2-ethanediamines.
2-噁唑啉酮或其N-取代衍生物在高温下与芳香胺盐酸盐反应,生成1,2-乙二胺。
C-28 AMIDES OF MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS
申请人:Regueiro-Ren Alicia
公开号:US20120142653A1
公开(公告)日:2012-06-07
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, modified C-3 and C-28 betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors. These compounds are useful for the treatment of HIV and AIDS.
Novel cinnamamide derivatives and the salts thereof are provided. An antihyperlipidemic composition is also provided. The composition comprises an active ingredient which is at least one selected from the group consisting of the above-mentioned cinnamamide derivative and the pharmaceutically acceptable salt thereof.